Spikevax (Moderna mRNA-1273 COVID-19 vaccine) living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study

	COVID-19 severe or critically

	COVID-19 prophylaxis (excluding children)
Spikevax (Moderna mRNA-1273 COVID-19 vaccine)	Pawlowski Klein Husby ... Southern California ... Southern California ... COVE Moderna/NIH phase 3 ... Moderna study 201 100µg Benotmane

4888	study 101 dose finding, 2020	2	31	0	excluded	not a RCT	risk of bias not avaialble
6054	Moderna preclinical (Corbett), 2020	2	1	0	excluded		risk of bias not avaialble